| Day 1 - Morning
Session |
| Part I: Welcome and Keynote
Address |
| 8:00 A.M. |
Introductory comments:
Drs. Claude Lenfant, Aram Chobanian, and Martha Hill |
| 8:20 A.M. |
Overview of the relationship
between sodium and blood pressure
Dr. Paul Whelton |
| Part II: Response to Dietary
Sodium and Other Nutrients |
| 8:50 A.M. |
Differences in dietary
responsiveness to sodium intake
Dr. Myron Weinberger |
| 9:05 A.M. |
Discussion--Leaders: Drs. Margo
Denke, John Flack, and Steven Hunt |
| 9:35 A.M. |
Interactions of sodium,
potassium, magnesium and calcium in the regulation of blood pressure
Dr. Frank Sacks |
| 9:50 A.M. |
Discussion--Leaders: Drs. Theodore
Kotchen, David McCarron, and Laura Svetkey |
| 10:15 A.M. |
BREAK |
| Part III: Sodium and Blood
Pressure in the Young |
| 10:30 A.M. |
Effects of neonatal sodium intake
Dr. Ronald Prineas |
| 10:45 A.M. |
Sodium intake and blood pressure
in children
Dr. Bonita Falkner |
| 11:00 A.M. |
Discussion--Leaders: Drs. Gerald
Berenson, Clarence Grim, and Julie Ingelfinger |
| 11:30 A.M. |
General Discussion |
| 12:00-1:00 P.M. |
LUNCH |
| Day 1 - Afternoon
Session |
| Part IV: Clinical Trials and
Clinical Studies |
| 1:00 P.M. |
Meta-analysis of clinical trials
of sodium reduction:
Dr. Niels Graudal |
| 1:20 P.M. |
Sodium reduction in
subpopulations (age, race, gender):
Dr. Richard Grimm |
| 1:40 P.M. |
The prevalence of sodium
sensitivity in postmenopausal women:
Dr. Janice Douglas |
| 2:00 P.M. |
Sodium reduction and quality of
life:
Dr. Shiriki Kumanyika |
| 2:20 P.M. |
Discussion--Leaders: Drs. Lawrence
Appel, David Freedman, Diana Petitti, James Robins, and Michael Stoto |
| 3:00 P.M. |
BREAK |
| Part V: Observational
Studies |
| 3:15 P.M. |
INTERSALT:
Dr. Paul
Elliott |
| 3:30 P.M. |
Worksite Cohort, NHANES I, and
Scotland Study
Dr. Christopher Sempos |
| 3:45 P.M. |
MRFIT-Followup:
Dr. Jerome
Cohen |
| 4:00 P.M. |
Discussion--Leaders: Drs. Nancy
Cook, Graham MacGregor, and Louis Tobian |
| 4:45 P.M. |
ADJOURNMENT |
| Day 2 - Morning
Session |
| Part VI: Other Data |
| 8:00 A.M. |
Non-CVD conditions:
Dr.
Daniel Jones |
| 8:15 A.M. |
Left ventricular mass:
Dr.
Richard Devereaux |
| 8:30 A.M. |
Discussion--Leaders: Drs. Jay Cohn,
Edward Frohlich and Lewis Kuller |
| Part VII: Physiological Effects of
Very Low Sodium Intake |
| 9:00 A.M. |
Renin-angiotensin
system:
Dr. Suzanne Oparil |
| 9:15 A.M. |
Sympathetic nervous
system:
Dr. Allyn Mark |
| 9:30 A.M. |
Plasma insulin, cholesterol and
coagulation factors:
Dr. Brent M. Egan |
| 9:45 A.M. |
Discussion--Leaders: Drs. Richard
Cooper, Carlos Ferrario, and Gordon Williams |
| 10:15 A.M. |
BREAK |
| Part VIII: Research Needs |
| 10:30 A.M. |
Basic research:
Dr. Allen
Cowley |
| 10:50 A.M. |
Clinical/epidemiological
research:
Dr. Lawrence Appel |
| 11:10 A.M. |
Discussion--Leaders: Drs. Harry
Gavras, David Goff, John Hall, and John McGiff |
| 11:40 A.M. |
Should there be a randomized
clinical trial on sodium reduction and blood pressure with morbidity/mortality
as an outcome?
Drs. Daniel Jones, Alexander Logan, Ronald Prineas, and
Jeremiah Stamler |
| 12:00 |
General discussion: research
considerations |
| 12:30-1:30 P.M. |
LUNCH |
| Day 2 - Afternoon
Session |
| Part IX: Public Policy
Considerations |
| 1:30 P.M. |
Dietary guidance public
policy:
Dr. Michael McGinnis |
| 1:50 P.M. |
Discussion--Leaders: Drs. Johanna
Dwyer, William Harlan, Marion Nestle, and Meir Stampfer |
| 2:30 P.M. |
General discussion: policy
considerations |
| 3:15 P.M. |
Chairpersons' concluding
remarks |
| 3:45 P.M. |
ADJOURNMENT |
HOME
Department of Health
and Human Services
National
Institutes of Health
National Heart, Lung, and Blood
Institute